Table 4.
Acute n = 32 (40.0%) |
Chronic n = 48 (60.0%) |
P | |
---|---|---|---|
No treatment | 1 (3.1%) | 6 (12.5%) | 0.078 |
General treatment | 21 (65.6%) | 31 (64.6%) | |
General treatment + immunosuppressants | 1 (3.1%) | 5 (10.4%) | |
General treatment + UDCA | 8 (25%) | 3 (6.3%) | |
General treatment + immunosuppressants + UDCA | 1 (3.1%) | 3 (6.3%) | |
| |||
Time of treatment (months) | 2 (0.50, 12) | 1 (0.33, 12) | 0.805 |